Modalis Therapeutics
4883.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Evo Fund | 7.61% |
| Life Science Innovation Management Inc. | 6.28% |
| LSIM Inc. | 5.02% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| SBI SECURITIES Co., Ltd. | 3.77% |
| Osamu Nureki | 3.58% |
| SBI Investment Co., Ltd. | 0.69% |
| Haruhiko Morita | 0.38% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 177
| Holder | Ratio | Change |
|---|---|---|
| Evolution Capital Management LLC2025-01-30 · amended | 0.00% | no change |
| Evo Fund2025-01-30 · amended | 11.04% | -2.26pp |
| SBI Investment Co., Ltd.2025-01-22 · amended | 0.69% | no change |
| SBI SECURITIES Co., Ltd.2025-01-22 · amended | 3.77% | +0.34pp |
| SBI Investment Co., Ltd.2024-12-23 · amended | 0.69% | -1.01pp |
| SBI SECURITIES Co., Ltd.2024-12-23 · amended | 3.43% | +0.42pp |
| SBI Investment Co., Ltd.2024-11-22 · amended | 1.70% | -0.39pp |
| SBI SECURITIES Co., Ltd.2024-11-22 · amended | 3.01% | +0.73pp |
| Evolution Capital Management LLC2024-11-06 · amended | 0.00% | no change |
| Evo Fund2024-11-06 · amended | 13.30% | -1.85pp |
| Evolution Capital Management LLC2024-11-05 · amended | 0.00% | no change |
| Evo Fund2024-11-05 · amended | 15.15% | -5.62pp |
| Evolution Capital Management LLC2024-10-18 · amended | 0.00% | no change |
| Evo Fund2024-10-18 · amended | 20.77% | -0.25pp |
| Evolution Capital Management LLC2024-10-16 · amended | 0.00% | no change |
| Evo Fund2024-10-16 · amended | 21.02% | -1.12pp |
| Evolution Capital Management LLC2024-10-15 · amended | 0.00% | no change |
| Evo Fund2024-10-15 · amended | 22.14% | -1.87pp |
| Evolution Capital Management LLC2024-10-09 · amended | 0.00% | no change |
| Evo Fund2024-10-09 · amended | 24.01% | -1.05pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.